Q4 2025 13F Holders as of 31 Dec 2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
140,036,400
-
Total 13F shares
-
81,384,599
-
Share change
-
+968,610
-
Total reported value
-
$63,802,481
-
Price per share
-
$0.78
-
Number of holders
-
34
-
Value change
-
+$769,162
-
Number of buys
-
14
-
Number of sells
-
14
Institutional Holders of Xtant Medical Holdings, Inc. - Common Stock (XTNT) as of Q4 2025
As of 31 Dec 2025,
Xtant Medical Holdings, Inc. - Common Stock (XTNT) was held by
34 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
81,384,599 shares.
The largest 10 holders included
Nantahala Capital Management, LLC, AWM Investment Company, Inc., VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, GEODE CAPITAL MANAGEMENT, LLC, Crescent Grove Advisors, LLC, Hillsdale Investment Management Inc., CITADEL ADVISORS LLC, NANO CAP NEW MILLENNIUM GROWTH FUND L P, and ACADIAN ASSET MANAGEMENT LLC.
This page lists
35
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.